Here using tissue microarray, we identify nuclear p65 as a promising prognostic marker for GBM patients, and demonstrate the dual functions of NF‐κB in promoting tumourigenesis and chemosensitivity upon pre‐activated p65 at S536. The gene discussed is NFKB1; the disease is glioblastoma.